Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Hengsheng Pharmaceutical is a China-based pharmaceutical company dedicated to the research, development, and production of innovative drugs and high-quality generic medicines. Established in 1998, the company focuses primarily on therapeutic areas including cardiovascular and cerebrovascular diseases, metabolic disorders, and anti-infectives. It operates integrated R&D centers and GMP-certified manufacturing facilities to ensure the delivery of safe and effective treatments. Hengsheng is recognized for its expertise in chemical synthesis and advanced formulation technologies. The company maintains a strong presence in the domestic Chinese market while actively seeking international collaborations for its product pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Hengsheng Pharmaceutical.